The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Precision medicine has opened up a new era in the development of anti-cancer agents that is focused on identifying biomarkers predictive of treatment response regardless of tumor histology. Since 2017, the Food and Drug Administration has approved six drugs with histology-agnostic indications: pembr...

Descripción completa

Detalles Bibliográficos
Autores principales: Iannantuono, Giovanni Maria, Torino, Francesco, Rosenfeld, Roberto, Guerriero, Simona, Carlucci, Manuela, Sganga, Stefano, Capotondi, Barbara, Riondino, Silvia, Roselli, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369092/
https://www.ncbi.nlm.nih.gov/pubmed/35955671
http://dx.doi.org/10.3390/ijms23158535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369092/
https://www.ncbi.nlm.nih.gov/pubmed/35955671
http://dx.doi.org/10.3390/ijms23158535

Ejemplares similares